With our GenAI Discovery models, we advance our pipeline of eukaryotic initiation factors 90% faster than with classical research methods achievable.

WORLD’s FIRST BIOMARKER BASED on LAB ON THE CHIP CARTRIDGE HAS BEEN DELIVERED in 2023 within our partnership with BOSCH Healthcare Solutions.






Prof.Dr.Dr. Johannes Haeybäck
Principal Scientist / Medical Research Advisory


Contact our science team